Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72.

2.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
3.

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Sep 16;351:h4320. doi: 10.1136/bmj.h4320.

4.

Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.

Chiu HJ, Hong CJ, Chan CH.

Zhonghua Yi Xue Za Zhi (Taipei). 1996 Jun;57(6):418-23.

PMID:
8803304
5.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
6.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
7.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
8.

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD.

Am J Psychiatry. 2001 Jun;158(6):906-12.

PMID:
11384898
10.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
11.

Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP.

Am J Psychiatry. 1998 Mar;155(3):367-72.

PMID:
9501747
12.

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.

Braconnier A, Le Coent R, Cohen D; DEROXADO Study Group..

J Am Acad Child Adolesc Psychiatry. 2003 Jan;42(1):22-9.

PMID:
12500073
13.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
15.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.

JAMA. 1998 Jan 28;279(4):287-91.

PMID:
9450712
16.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
17.

A placebo- and imipramine-controlled study of paroxetine.

Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.

Psychopharmacol Bull. 1990;26(2):185-9.

PMID:
2146697
18.
19.

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.

J Clin Psychiatry. 2003 Apr;64(4):413-20.

PMID:
12716243
20.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
Items per page

Supplemental Content

Support Center